Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

2.2K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.2K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

573
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
573
Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

7.2K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
7.2K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

779
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
779

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.

Clinical toxicology (Philadelphia, Pa.)·2026
Same author

Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study.

Translational psychiatry·2026
Same author

Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study.

BMJ open·2026
Same author

Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment.

Cell reports. Medicine·2026
Same author

Ibogalogs and their pyridoindole homologs activate or inhibit the 5-HT<sub>2B</sub> receptor by modulating the distance between transmembrane segments TM3 and TM6 in the orthosteric site.

European journal of pharmacology·2026
Same author

5-HT<sub>2A</sub> receptor agonism by tert-leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence.

British journal of pharmacology·2026
Same journal

Glutamate-Glutamine metabolism and transport, implications in Parkinson's disease.

International review of neurobiology·2026
Same journal

Redox bioenergetics of neuronal senescence in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Neurovascular coupling and energy substrate delivery in Alzheimer's disease.

International review of neurobiology·2026
Same journal

From metals to mitochondria: Linking trace elements to energy crisis in Alzheimer's disease.

International review of neurobiology·2026
Same journal

Invisible threats of microplastics induced toxicity: Oxidative and inflammatory pathways in the CNS and retina.

International review of neurobiology·2026
Same journal

Starved synapses: Gut microbiome dysbiosis and its role in Alzheimer's glucose impairment.

International review of neurobiology·2026
See all related articles

Related Experiment Video

Updated: Sep 18, 2025

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.9K

Clinical pharmacology.

Severin B Vogt1, Matthias E Liechti1

  • 1Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.

International Review of Neurobiology
|June 20, 2025
PubMed
Summary
This summary is machine-generated.

Understanding the clinical pharmacology of psychedelics like psilocybin and MDMA is key for therapeutic trials. While psychedelics share similar effects via 5-HT2A receptors, their pharmacokinetics vary, impacting therapeutic use.

Keywords:
Drug-drug interactionMetabolismPharmacodynamicsPharmacokinetics

More Related Videos

Novel Apparatus and Method for Drug Reinforcement
07:32

Novel Apparatus and Method for Drug Reinforcement

Published on: August 20, 2010

19.3K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K

Related Experiment Videos

Last Updated: Sep 18, 2025

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

9.9K
Novel Apparatus and Method for Drug Reinforcement
07:32

Novel Apparatus and Method for Drug Reinforcement

Published on: August 20, 2010

19.3K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K

Area of Science:

  • Pharmacology
  • Clinical Trials
  • Psychoactive Substances

Background:

  • Clinical pharmacology is essential for designing therapeutic trials and selecting appropriate drug doses.
  • Recent research has focused on the human pharmacology of psychedelics and MDMA.
  • Understanding these substances is crucial for advancing their clinical applications.

Purpose of the Study:

  • To summarize the pharmacological characteristics of various serotonergic psychedelics and MDMA.
  • To review human data from modern clinical trials regarding mechanisms of action, pharmacokinetics, pharmacodynamics, metabolism, and safety.
  • To provide recommendations for dosing, dose adjustment, and drug interactions.

Main Methods:

  • Review of existing literature and clinical trial data on psilocybin, LSD, mescaline, DMT, 5-MeO-DMT, and MDMA.
  • Analysis of pharmacological profiles, including receptor interactions, pharmacokinetic-pharmacodynamic relationships, and tolerance.
  • Synthesis of safety data and clinical recommendations.

Main Results:

  • Serotonergic psychedelics (psilocybin, LSD, mescaline, DMT, 5-MeO-DMT) produce comparable acute effects via 5-HT2A receptor interaction, but differ in pharmacokinetics and metabolism, influencing duration of action.
  • MDMA exhibits a distinct profile with stimulant-like and empathogenic effects, and shows acute pharmacological tolerance, unlike psychedelics.
  • Therapeutic benefits of psychedelics require further elucidation, despite comparable acute effects.

Conclusions:

  • A comprehensive understanding of the pharmacology of classic psychedelics and MDMA is foundational for their clinical use and the design of effective therapeutic trials.
  • Differences in pharmacokinetics and metabolism among psychedelics necessitate careful consideration for specific therapeutic indications.
  • MDMA's unique psychopharmacological profile and tolerance suggest distinct therapeutic applications compared to classic psychedelics.